{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:23:54Z","timestamp":1792686234163,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,6,6]],"date-time":"2016-06-06T00:00:00Z","timestamp":1465171200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.ahj.2016.05.007","type":"journal-article","created":{"date-parts":[[2016,5,17]],"date-time":"2016-05-17T13:17:27Z","timestamp":1463491047000},"page":"126-134","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":151,"special_numbering":"C","title":["Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF)"],"prefix":"10.1016","volume":"178","clinical-trial-number":[{"clinical-trial-number":"nct01839357","registry":"10.18810\/clinical-trials-gov"},{"clinical-trial-number":"nct01928979","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Gregory Y.H.","family":"Lip","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Hammerstingl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco","family":"Marin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Cappato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle Ling","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bodo","family":"Kirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"van Eickels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2016.05.007_bb0005","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1093\/eurheartj\/ehq278","article-title":"Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC)","volume":"31","author":"Camm","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2016.05.007_bb0010","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0140-6736(09)60040-4","article-title":"Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited","volume":"373","author":"Watson","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2016.05.007_bb0015","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1136\/hrt.82.5.547","article-title":"Left atrial appendage: structure, function, and role in thromboembolism","volume":"82","author":"Al Saady","year":"1999","journal-title":"Heart"},{"key":"10.1016\/j.ahj.2016.05.007_bb0020","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1161\/01.CIR.89.6.2509","article-title":"Exclusion of atrial thrombus by transesophageal echocardiography does not preclude embolism after cardioversion of atrial fibrillation. A multicenter study","volume":"89","author":"Black","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2016.05.007_bb0025","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S0735-1097(00)01178-5","article-title":"Role of transesophageal echocardiography-guided cardioversion of patients with atrial fibrillation","volume":"37","author":"Klein","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2016.05.007_bb0030","doi-asserted-by":"crossref","first-page":"817","DOI":"10.7326\/0003-4819-123-11-199512010-00001","article-title":"Accuracy of transesophageal echocardiography for identifying left atrial thrombi. A prospective, intraoperative study","volume":"123","author":"Manning","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2016.05.007_bb0035","first-page":"e269","volume":"123","author":"Fuster","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2016.05.007_bb0040","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ijcard.2003.10.019","article-title":"Cardioversion under the guidance of transesophageal echochardiograhy in persistent atrial fibrillation: results with low molecular weight heparin","volume":"98","author":"Akdeniz","year":"2005","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2016.05.007_bb0045","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1161\/01.CIR.92.2.160","article-title":"Cardioversion of nonrheumatic atrial fibrillation. Reduced thromboembolic complications with 4 weeks of precardioversion anticoagulation are related to atrial thrombus resolution","volume":"92","author":"Collins","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2016.05.007_bb0050","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1378\/chest.115.1.140","article-title":"Atrial thrombi resolution after prolonged anticoagulation in patients with atrial fibrillation","volume":"115","author":"Corrado","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.ahj.2016.05.007_bb0055","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1067\/mhj.2000.106648","article-title":"Efficacy of anticoagulation in resolving left atrial and left atrial appendage thrombi: a transesophageal echocardiographic study","volume":"140","author":"Jaber","year":"2000","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2016.05.007_bb0060","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.ijcard.2006.03.036","article-title":"Role of transesophageal echocardiography guided cardioversion in patients with atrial fibrillation, previous left atrial thrombus and effective anticoagulation","volume":"113","author":"Saeed","year":"2006","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ahj.2016.05.007_bb0065","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/S0735-1097(02)01785-0","article-title":"Embolic events in patients with atrial fibrillation and effective anticoagulation: value of transesophageal echocardiography to guide direct-current cardioversion. Final results of the Ludwigshafen Observational Cardioversion Study","volume":"39","author":"Seidl","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2016.05.007_bb0070","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1093\/eurheartj\/ehs253","article-title":"2012 Focused update of the ESC guidelines for the management of atrial fibrillation: an update of the 2010 ESC guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart Rhythm Association","volume":"33","author":"Camm","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2016.05.007_bb0075","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jjcc.2011.06.009","article-title":"Left atrial thrombus and prognosis after anticoagulation therapy in patients with atrial fibrillation","volume":"58","author":"Fukuda","year":"2011","journal-title":"J Cardiol"},{"key":"10.1016\/j.ahj.2016.05.007_bb0080","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1016\/j.jacc.2013.02.025","article-title":"Outcomes following cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial","volume":"61","author":"Piccini","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.ahj.2016.05.007_bb0085","first-page":"781","article-title":"Non-vitamin K antagonist oral anticoagulants (NOACs): no longer new or novel","volume":"111","author":"Husted","year":"2014","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ahj.2016.05.007_bb0090","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2014-203870","article-title":"Use of apixaban for an elderly patient with left atrial thrombus","volume":"2014","author":"Dobashi","year":"2014","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.ahj.2016.05.007_bb0095","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1160\/TH12-11-0821","article-title":"Resolution of giant left atrial appendage thrombus with rivaroxaban","volume":"109","author":"Hammerstingl","year":"2013","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.ahj.2016.05.007_bb0100","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1477-9560-11-26","article-title":"Resolution of left atrial appendage thrombus with apixaban","volume":"11","author":"Kawakami","year":"2013","journal-title":"Thromb J"},{"key":"10.1016\/j.ahj.2016.05.007_bb0105","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000354315","article-title":"Dissolution of the left atrial appendage thrombus with rivaroxaban therapy","volume":"36","author":"Takasugi","year":"2013","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/j.ahj.2016.05.007_bb0110","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s11239-012-0747-1","article-title":"Dabigatran and left atrial appendage thrombus","volume":"34","author":"Vidal","year":"2012","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.ahj.2016.05.007_bb0115","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.ahj.2014.12.020","volume":"169","author":"Lip","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2016.05.007_bb0120","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ahj.2016.05.007_bb0125","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s00392-015-0883-7","article-title":"Rationale and design of the RE-LATED AF-AFNET 7 trial: REsolution of Left atrial-Appendage Thrombus\u2014Effects of Dabigatran in patients with Atrial Fibrillation","volume":"105","author":"Ferner","year":"2016","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.ahj.2016.05.007_bb0130","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/j.amjcard.2004.06.010","article-title":"Fate of left atrial thrombi in patients with atrial fibrillation determined by transesophageal echocardiography and cerebral magnetic resonance imaging","volume":"94","author":"Bernhardt","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.ahj.2016.05.007_bb0135","article-title":"XANTUS: a real-world, prospective, observational study of patients treated with rivaroxaban for stroke prevention in atrial fibrillation","author":"Camm","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ahj.2016.05.007_bb0140","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870316300643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870316300643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:55:49Z","timestamp":1757570149000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870316300643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":28,"alternative-id":["S0002870316300643"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2016.05.007","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Left atrial thrombus resolution in atrial fibrillation or flutter: Results of a prospective study with rivaroxaban (X-TRA) and a retrospective observational registry providing baseline data (CLOT-AF)","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2016.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}